Ergotamine D-tartrate (CAS 379-79-3) Market Research Report 2024

November 2024 | 50 pages | ID: E78BE6F7E73EN
BAC Reports

Abstracts

Ergotamine D-tartrate (CAS 379-79-3) Market Research Report 2024 presents comprehensive data on Ergotamine D-tartrate markets globally and regionally (Europe, Asia, North America etc.)

The report includes Ergotamine D-tartrate description, covers its application areas and related patterns. It overviews Ergotamine D-tartrate market, names Ergotamine D-tartrate producers and indicates its suppliers.

Besides, the report provides Ergotamine D-tartrate prices in regional markets.

In addition to the above the report determines Ergotamine D-tartrate consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

• capacities and production
• consumption volume and structure
• market price trends
• exports and imports
• existing technologies
• feedstock market condition
• market news digest
• market forecast.

Ergotamine D-tartrate (CAS 379-79-3) Market Research Report 2024 can feature:

• market condition and estimations, market forecast
• chemical product ranges, trademarks, analogous products, application areas
• regional and global producers, consumers and traders (including contact details).

Contents

1. ERGOTAMINE D-TARTRATE (CAS 379-79-3)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. ERGOTAMINE D-TARTRATE APPLICATIONS

2.1. Ergotamine D-tartrate application spheres, downstream products

3. ERGOTAMINE D-TARTRATE MANUFACTURING METHODS

4. ERGOTAMINE D-TARTRATE PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. ERGOTAMINE D-TARTRATE MARKET WORLDWIDE 

5.1. General Ergotamine D-tartrate market situation, trends
5.2. Manufacturers of Ergotamine D-tartrate
- Europe
- Asia
- North America
- Other regions
5.3. Ergotamine D-tartrate suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Ergotamine D-tartrate market forecast

6. ERGOTAMINE D-TARTRATE MARKET PRICES

6.1. Ergotamine D-tartrate prices in Europe
6.2. Ergotamine D-tartrate prices in Asia
6.3. Ergotamine D-tartrate prices in North America
6.4. Ergotamine D-tartrate prices in other regions

7. ERGOTAMINE D-TARTRATE END-USE SECTOR 

7.1. Ergotamine D-tartrate market by application sphere
7.2. Ergotamine D-tartrate downstream markets trends and prospects

*Please note that Ergotamine D-tartrate (CAS 379-79-3) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

About

Product Name:	Ergotamine D-tartrate
Synonyms:	Ergotamine tartrate (5'α)-5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate
CAS#:	379-79-3

Ergotamine tartrate (etin, ergate, exmigra, secagyn, femergin, etc.) is a solid or liquid white drug with the molecular formula C₇₀H₇₆N₁₀O₁₆. Ergotamine tartrate is slightly soluble in water and ethanol and almost insoluble in ether R, benzene R, and light petroleum R.

The drug is available in the form of tablets and rectal suppositories. Ergotamine tartrate is utilized in the treatment of cluster headache or migraines. The medication is used in obstetrics. The ergotamine tartrate may significantly decrease the severe pain and painful episodes if the drug is taken at the first signs of a migraine.

The drug in combination with caffeine stimulates the release of the neurotransmitters epinephrine, serotonin, and dopamine that fight spikes in the blood circulation.

Vomiting, diarrhea, thirst, tingling of fingers and toes, and increased blood pressure are amid the acute side effects of the drug. Besides, ergotamine tartrate causes a rapid heart rate, chest pains, breathing difficulties, or numbness in the extremities. The drug can entail eyes, skin, respiratory tract irritation.

Ergotamine tartrate market is covered in the study Ergotamine tartrate (CAS 379-79-3) Market Research Report 2013. The report encompasses proper description of the product, unveils application areas, and briefly summarizes patents in the sphere. It overlooks ergotamine tartrate market situation, names manufacturers, suppliers as well as users. The report also provides current ergotamine tartrate prices in the market.